5:08 PM
 | 
Jan 18, 2013
 |  BC Extra  |  Politics & Policy

Katz retiring from FDA

Russell Katz is retiring as director of the Division of Neurology Products in FDA's Center...

Read the full 54 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >